Back to
STATE STREET CORP
URGN28 quarters
Position history for
STATE STREET CORP's holdings in UROGEN PHARMA LTD
Yes. State Street holds 1,003,071 shares of URGN (Urogen Pharma), worth $36.9M, as of its Q2 2026 13F filing. It increased the position by 128,895 shares (+14.7%) from Q1 2026. State Street has held URGN in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$36.9M
Current Shares
1M
Total Value Change
+$27.7M
Total Shares Change
+615,242
Quarter-by-Quarter History
Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.